Stay updated on BI 695501 vs Adalimumab in Active RA Clinical Trial
Sign up to get notified when there's something new on the BI 695501 vs Adalimumab in Active RA Clinical Trial page.

Latest updates to the BI 695501 vs Adalimumab in Active RA Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page footer now shows Revision: v3.6.5, replacing the previous v3.6.4, indicating a version update in the site's underlying framework rather than changes to study content.SummaryDifference0.0%

- Check17 days agoChange DetectedThe study's locations list now uses Zaporizhzhya, Ukraine, 69600 instead of Zaporizhzhia, Ukraine, 69600. This updates the transliteration of the city name while keeping the same postal code.SummaryDifference0.0%

- Check24 days agoChange DetectedRevision: v3.6.4 replaces the prior Revision: v3.6.3 on the page, indicating a small backend or template update. This appears to be a platform-level change rather than a modification to the study data or its presentation.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision: v3.6.3 was added and Revision: v3.6.2 was removed, indicating a minor version update to the page. This change affects only the page metadata, not the study details or data.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page revision tag was updated to v3.6.2, replacing the previous v3.6.0 to indicate a minor metadata update to the study record.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page now shows a recruitment-closure notice ('No longer looking for participants'), and adds user guidance sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'). It also updates the Interventions header formatting from 'Intervention / Treatment' to 'Intervention/Treatment' and changes the revision footer from v3.5.5 to v3.6.0.SummaryDifference0.2%

Stay in the know with updates to BI 695501 vs Adalimumab in Active RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 695501 vs Adalimumab in Active RA Clinical Trial page.